VLV Technology is developing AI-powered portable platforms designed to bring clinical-grade diagnostics to point-of-care and low-resource settings — environments where traditional imaging infrastructure cannot reach.
At the core of the platform is a real-time signal processing pipeline that interprets ultrasound data and delivers clinically relevant output on compact, embedded hardware — without sacrificing diagnostic performance.
Driving the company’s vision is Akhil John Thomas, Product Lead, whose background spans AI system design, product strategy, and clinical innovation. “Our focus is on removing the barriers between powerful technology and the people who need it most — building systems that are easy to deploy, high-performing, and designed for the real world.”
The company’s roadmap extends beyond diagnostics into therapeutic applications, positioning VLV as a long-term infrastructure provider for decentralised healthcare. Near-term priorities include clinical partnerships, real-world testing, and regulatory compliance.
The global point-of-care diagnostics market is valued at over $150 billion and growing, driven by aging populations and the expansion of care beyond centralised systems. VLV Technology enters this space with validated technology and deep domain expertise.
About VLV Technology
VLV Technology develops portable systems for point-of-care and low-resource clinical settings, combining advanced signal processing, embedded AI, and portable hardware. For more information, visit www.vlvtechnology.com.
